SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Starknet

STRKs sharp rally has drawn attention to Starknets privacy and Bitcoin DeFi push, particularly shielded strkBTC and STRK20, alongside its post-quantum security positioning. Bulls see these developments and ongoing network building as drivers, while skeptics highlight token-unlock dilution and the tokens weak longer-term performance.

Zillow Group, Inc. engages in the provision of real estate and home-related information marketplaces on mobile and the web. The company was founded by Richard N. Barton and Lloyd D. Frink in December 2004 and is headquartered in Seattle, WA.

Zillow Group Inc - Ordinary Shares - Class C

Zillow Group Inc Class C

Zillows selloff is drawing attention after Q2 results and a lower outlook: traders cite weaker expected residential revenue amid a sluggish housing market, despite revenue growth and strength in mortgages and rentals. Bulls call the decline an overreaction and point to growth and valuation, while bears focus on high mortgage rates, weak housing activity, and the guidance cut.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Attention centers on Compounds institutional-market push, including a reported launch, new leadership and investment plans, alongside anticipation for V4. Many traders are bullish on COMPs limited supply and potential breakout, while skeptics point to weak relative price action and concerns about protocol liquidity.

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

TAO is drawing attention around its volatile price action and Bittensors decentralized-AI and subnet thesis, with bulls citing ecosystem growth, revenue and tokenomics as reasons for interest. Others question whether real adoption and value capture justify the valuation, while noting the tokens exposure to broader crypto-market uncertainty.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Discussion centers on IntraBios reported acquisition, which traders are using as a valuation benchmark for Zevras Niemann-Pick franchise and as fuel for speculation that ZVRA could attract a buyer. Some see the recent strength as evidence the market is recognizing undervaluation, while others caution that the companies assets and prospects differ and that no buyout of Zevra is confirmed.

BNB is the native utility token of the BNB Chain ecosystem, acting as a multi-chain asset that powers decentralized applications and facilitates value exchange across its network. It serves as the primary asset for paying transaction gas and smart contract deployment fees while providing users with tiered fee discounts on the Binance exchange. The project’s main value proposition lies in its unified multi-chain architecture, which integrates a smart contract platform, a Layer 2 scaling solution, and a decentralized data storage network into a cohesive settlement and data availability layer.  The network operates on a Proof of Staked Authority consensus mechanism, utilizing a group of 21 active validators known as the Cabinet to verify transactions and produce blocks every 3 seconds. Validators are elected daily based on the amount of BNB staked or delegated to them, and the system employs fast finality and slashing penalties to maintain security and integrity. To manage its long-term economy, the project uses a programmatic dual-burn strategy that permanently removes tokens through real-time fee destruction and quarterly buybacks.  Launched in 2017 by the Binance platform, the project initially distributed 50% of its 200 million token supply to the public, while the founding team received 40% and angel investors were allocated 10%. Though it began as a token on the Ethereum network, it eventually migrated to its own autonomous architecture that remains fully compatible with the Ethereum Virtual Machine. Today, the token's utility includes paying for network gas, participating in staking rewards, and enabling decentralized governance through which holders can vote on technical upgrades and economic changes.

Binance

BNB is drawing attention for its rebound and ongoing consolidation, with traders sharing technical setups and watching whether momentum can extend. Bulls see room for further gains, while skeptics call the coin weak and expect a pullback.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEARs sharp rebound is drawing bullish attention, with traders pointing to renewed momentum and a possible breakout; the broader bull case centers on NEAR Intents activity and AI-agent infrastructure, while some remain cautious after recent volatility and an Intents exploit. The discussion is largely optimistic, but many cited upside scenarios are speculation.

iShares Bitcoin Trust ETF (The) - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin Trust ETF

Bitcoins rebound and consolidation are driving IBIT discussion, with many traders treating pullbacks as buying opportunities and anticipating further gains, while others warn that momentum could fade. The conversation is largely about Bitcoins direction rather than a confirmed IBIT-specific catalyst.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

Gold miners are drawing attention as traders assess whether GDXs correction is bottoming, with higher real yields and a stronger dollar cited as near-term pressure on gold and miners. Some see signs of a rebound and are buying dips, while others want confirmation and warn that the pullback may continue; longer-term bulls point to central-bank buying and concerns about debt and currency debasement.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

XCN is drawing attention amid a modest rebound and ongoing consolidation, with traders focused on chart levels, returning volume and the prospect of a breakout. Some are buying dips and expecting momentum to build, while others warn that thin volume and repeated rallies that fade make the move look like a pump-and-dump; broader crypto-market weakness is also cited.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Brief India: Aequitas: Shiprocket Limited Pre-IPO Tearsheet and more

In this briefing: Aequitas: Shiprocket Limited Pre-IPO Tearsheet Titan’s LGD Move: Expanding Diamond Adoption with BeYon Somany Ceramics: Recovery Building, Normalcy Distant. Maintain ADD Pharma and Healthcare (Q3FY26E Results Preview): Base business momentum to offset gRevlimid drag Aptus Value Housing Finance India: Value Emerging, Upgrade to ADD 1. Aequitas: Shiprocket Limited Pre-IPO Tearsheet Shiprocket Ltd (1087190D IN) plans to raise around US$253m in its upcoming India IPO. The deal will be run by Axis, BofA, JM Fin and Kotak. Shiprocket is a technology platform enabling small and medium businesses in India to sell online through their own websites, mobile apps, and social media channels efficiently. According to the Redseer report, Shiprocket was the largest new-age end-to-end horizontal e-commerce enablement platform in terms of revenue in FY25. 2. Titan’s LGD Move: Expanding Diamond Adoption with BeYon Titan delivered blockbuster jewellery performance despite a ~65% YoY surge in gold prices and launched beYon , its lab-grown diamond brand.

Brief Growth Ideas: Titan’s LGD Move: Expanding Diamond Adoption with BeYon and more

In this briefing: Titan’s LGD Move: Expanding Diamond Adoption with BeYon Primer: Piotech (688072 CH) - Jan 2026 Somany Ceramics: Recovery Building, Normalcy Distant. Maintain ADD Pharma and Healthcare (Q3FY26E Results Preview): Base business momentum to offset gRevlimid drag Aptus Value Housing Finance India: Value Emerging, Upgrade to ADD 1. Titan’s LGD Move: Expanding Diamond Adoption with BeYon Titan delivered blockbuster jewellery performance despite a ~65% YoY surge in gold prices and launched beYon , its lab-grown diamond brand. Strong pricing power funds experimentation; LGDs expand diamond adoption among younger buyers without cannibalizing natural diamonds. BeYon adds long-term relevance and optionality while the core jewellery engine remains cash generative. 2. Primer: Piotech (688072 CH) - Jan 2026 Piotech is a key beneficiary of China's strategic push for semiconductor self-sufficiency, driving substantial revenue growth and market share gains within the domestic market. The company exhibits a robust growth profile, evidenced by a significant increase in revenue and net income over the past three years, supported by strong demand for its core deposition equipment.

Brief India: Titan’s LGD Move: Expanding Diamond Adoption with BeYon and more

In this briefing: Titan’s LGD Move: Expanding Diamond Adoption with BeYon Somany Ceramics: Recovery Building, Normalcy Distant. Maintain ADD Pharma and Healthcare (Q3FY26E Results Preview): Base business momentum to offset gRevlimid drag Aptus Value Housing Finance India: Value Emerging, Upgrade to ADD Q3FY26 - Consolidated Earnings Preview 1. Titan’s LGD Move: Expanding Diamond Adoption with BeYon Titan delivered blockbuster jewellery performance despite a ~65% YoY surge in gold prices and launched beYon , its lab-grown diamond brand. Strong pricing power funds experimentation; LGDs expand diamond adoption among younger buyers without cannibalizing natural diamonds. BeYon adds long-term relevance and optionality while the core jewellery engine remains cash generative. 2. Somany Ceramics: Recovery Building, Normalcy Distant. Maintain ADD We attended Somany Ceramics' analyst meet, represented by Mr Abhishek Somany (MD and CEO), Mr Sailesh Kedawat (CFO), and Mr Ameya Somany (KMP – son of MD) Management indicated that demand is showing signs of recovery Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

Brief Growth Ideas: Primer: Piotech (688072 CH) - Jan 2026 and more

In this briefing: Primer: Piotech (688072 CH) - Jan 2026 Somany Ceramics: Recovery Building, Normalcy Distant. Maintain ADD Pharma and Healthcare (Q3FY26E Results Preview): Base business momentum to offset gRevlimid drag Aptus Value Housing Finance India: Value Emerging, Upgrade to ADD The Cuban Gold Rush? 1. Primer: Piotech (688072 CH) - Jan 2026 Piotech is a key beneficiary of China's strategic push for semiconductor self-sufficiency, driving substantial revenue growth and market share gains within the domestic market. The company exhibits a robust growth profile, evidenced by a significant increase in revenue and net income over the past three years, supported by strong demand for its core deposition equipment. Valuation appears stretched, with key multiples trading at a significant premium to global peers, reflecting high growth expectations but also posing a risk of de-rating if execution falters or market conditions change. This content is AI-generated and displayed for general informational purposes only.

Brief Growth Ideas: Somany Ceramics: Recovery Building, Normalcy Distant. Maintain ADD and more

In this briefing: Somany Ceramics: Recovery Building, Normalcy Distant. Maintain ADD Pharma and Healthcare (Q3FY26E Results Preview): Base business momentum to offset gRevlimid drag Aptus Value Housing Finance India: Value Emerging, Upgrade to ADD The Cuban Gold Rush? The Gfc Distressed Preferred Stock Opportunity (Fnmat & More) 1. Somany Ceramics: Recovery Building, Normalcy Distant. Maintain ADD We attended Somany Ceramics' analyst meet, represented by Mr Abhishek Somany (MD and CEO), Mr Sailesh Kedawat (CFO), and Mr Ameya Somany (KMP – son of MD) Management indicated that demand is showing signs of recovery Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below. 2. Pharma and Healthcare (Q3FY26E Results Preview): Base business momentum to offset gRevlimid drag The India Pharma and Healthcare sector is expected to see moderate revenue growth as EBITDA margins remain flat We project sales/EBITDA growth of 11%/10% YoY for our coverage universe Our assumptions are: (1) Pharma coverage will see 10% YoY sales growth driven by 11% YoY increase in the India business Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

Brief India: Somany Ceramics: Recovery Building, Normalcy Distant. Maintain ADD and more

In this briefing: Somany Ceramics: Recovery Building, Normalcy Distant. Maintain ADD Pharma and Healthcare (Q3FY26E Results Preview): Base business momentum to offset gRevlimid drag Aptus Value Housing Finance India: Value Emerging, Upgrade to ADD Q3FY26 - Consolidated Earnings Preview Minda Corporation Ltd- Forensic Analysis 1. Somany Ceramics: Recovery Building, Normalcy Distant. Maintain ADD We attended Somany Ceramics' analyst meet, represented by Mr Abhishek Somany (MD and CEO), Mr Sailesh Kedawat (CFO), and Mr Ameya Somany (KMP – son of MD) Management indicated that demand is showing signs of recovery Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below. 2. Pharma and Healthcare (Q3FY26E Results Preview): Base business momentum to offset gRevlimid drag The India Pharma and Healthcare sector is expected to see moderate revenue growth as EBITDA margins remain flat We project sales/EBITDA growth of 11%/10% YoY for our coverage universe Our assumptions are: (1) Pharma coverage will see 10% YoY sales growth driven by 11% YoY increase in the India business Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

Brief Growth Ideas: Pharma and Healthcare (Q3FY26E Results Preview): Base business momentum to offset gRevlimid drag and more

In this briefing: Pharma and Healthcare (Q3FY26E Results Preview): Base business momentum to offset gRevlimid drag Aptus Value Housing Finance India: Value Emerging, Upgrade to ADD The Cuban Gold Rush? The Gfc Distressed Preferred Stock Opportunity (Fnmat & More) Q3FY26 - Consolidated Earnings Preview 1. Pharma and Healthcare (Q3FY26E Results Preview): Base business momentum to offset gRevlimid drag The India Pharma and Healthcare sector is expected to see moderate revenue growth as EBITDA margins remain flat We project sales/EBITDA growth of 11%/10% YoY for our coverage universe Our assumptions are: (1) Pharma coverage will see 10% YoY sales growth driven by 11% YoY increase in the India business Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below. 2. Aptus Value Housing Finance India: Value Emerging, Upgrade to ADD APTUS remains focused on the core customer segment - LIG, self-employed and rural-based customers, constituting >70% of AUM to scale up its portfolio to INR 250bn by FY29 The company’s superior profitability (~7.5% RoA, ~19-20% RoE) stems from strong risk-adjusted yields (~17%), superior operating efficiency (CI at 20%, opex to assets at 2.7%) and low leverage (D/E at 1.6x) However, APTUS’s scalability outside core markets and core products has been protracted over the last few years Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

Brief Equities Bottom-Up: Aptus Value Housing Finance India: Value Emerging, Upgrade to ADD and more

In this briefing: Aptus Value Housing Finance India: Value Emerging, Upgrade to ADD Samsung Electronics (005930 KS Jan 8, 2025) - No Signs of Slowing Vale Indonesia (INCO.IJ) On-Track Ore Monetization to Drive FY26-27 Earnings S-Oil (010950 KS/Buy)Refining Margins to Remain Strong into 2026 LODE: Final Permitting Paves Way for Silver Springs Facility Commissioning 1. Aptus Value Housing Finance India: Value Emerging, Upgrade to ADD APTUS remains focused on the core customer segment - LIG, self-employed and rural-based customers, constituting >70% of AUM to scale up its portfolio to INR 250bn by FY29 The company’s superior profitability (~7.5% RoA, ~19-20% RoE) stems from strong risk-adjusted yields (~17%), superior operating efficiency (CI at 20%, opex to assets at 2.7%) and low leverage (D/E at 1.6x) However, APTUS’s scalability outside core markets and core products has been protracted over the last few years Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

Indian Markets Reverse Early Gains: Yes Bank, Adani, Vodafone Shares Under Pressure

Equity

Nifty consolidates below key resistance level. An analyst flags 24,800 as the breakout level, while broader indices outperform. 


Aptus Value Housing Finance India Ltd. engages in the provision of housing finance needs of low income and middle income customers. Its products include home loans, non-housing loan, insurance services, and loan against property. The company was founded by Munusamy Anandan on December 11, 2009 and is headquartered in Chennai, India.

Current Price	215.00
Prev Close	217.89
Open	215.52
Dividend Yield	2.31%
50-Day Moving Average	247.85
Beta	-0.06
Avg. Volume	1.72M
PE Ratio	10.97

52-Week High	322.75
52-Week Low	193.03
Market Capitalization	108.15B
EPS (Annual)	18.84
Price to Book	2.13
Revenue Per Employee	5.89M

Feed

News

Sentiment

Fundamentals

Info

APTUS.NSE Fundamentals